by Aspirion | May 6, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
In this Q&A, Aspirion’s Rikki Ashkin, J.D., Senior Client Success Director, and Thomas Page, J.D., Sr. Director Ops Insights & Enablement, break down what extenuating circumstances are, how they apply across common authorization denial scenarios, and why...
by Aspirion | Apr 22, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published by Becker’s Healthcare, April 2026 | Author: Aspirion The Denial Crisis Isn’t a Documentation Problem Health systems treating rising denial rates as a documentation issue are misreading the situation. This is the output of a deliberate,...
by Aspirion | Apr 8, 2026 | Artificial Intelligence (AI), Denials Management, Out-of-Network Recovery
In this session, revenue cycle experts from Aspirion explore how clinical denial appeals and out-of-network disputes are more connected than most teams realize and how the same strategies winning one can strengthen the other. By the end of this session, you’ll...
by Aspirion | Mar 30, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published by Becker’s Healthcare, March 2026 | Author: Aspirion The Real Source of Rising Denial Rates Despite investments in Clinical Documentation Improvement programs, clinical denial rates keep climbing—not because of documentation failures, but because...
by Aspirion | Mar 18, 2026 | Artificial Intelligence (AI), Payment Variance Recovery, Revenue Cycle Management, Zero-Balance Review
Hospitals spend enormous energy chasing high-dollar denials. It makes intuitive sense—focus where the money is biggest. But this approach leaves a significant and largely invisible problem unaddressed: the accumulating weight of smaller denied claims that never get...
by Aspirion | Mar 4, 2026 | Artificial Intelligence (AI), Payment Variance Recovery, Revenue Cycle Management, Zero-Balance Review
Hospitals operate on razor-thin margins. For some health systems across the country, net margins hover below 5%—meaning every dollar of revenue carries significant weight. So when industry data suggests that a structured zero-balance review program can recover up...
